Comorbidities of onchocerciasis and non-communicable diseases, and determinants of continued transmission in Bafut Health District, Cameroon Authors: Irene U Ajonina-Ekoti, Promise A Aghaeze, Marcelus U Ajonina, Theresia Nkuo-Akenji Published: 2026 ABSTRACT AbstractBackgroundDespite decades of mass Ivermectin distribution, onchocerciasis transmission persists in Cameroon. Comorbidities with non-communicable diseases (NCDs) and gaps in treatment uptake may contribute to the sustained transmission of this disease. This study assessed the prevalence of onchocerciasis, its comorbidity with selected NCDs, and determinants of continued transmission in Bafut Health District, Cameroon.MethodsA community-based cross-sectional study with health facility-based recruitment was conducted from June to July 2024 among 282 adults aged 30 years or older who had resided in Bafut for at least 5 years. Data on sociodemographic, NCD history, onchocerciasis knowledge, and ivermectin uptake were collected using a structured questionnaire. Laboratory investigations included skin snip microscopy, nodule palpation, blood pressure measurement, and venous blood tests for diabetes and rheumatoid arthritis. The relationship between categorical variables was analysed using the Chi-square test and logistic regression at the 5% significance level.ResultsOf the 282 participants examined, 43 (15.2%) had palpable nodules, 17 (6.0%) were positive on skin snip for Onchocerca volvulus, and 6 (2.1%) had both palpable nodules and positive skin snip results. Onchocerciasis infection showed significant associations with sex, age group, marital status, and educational level (p < 0.05). Hypertension (27.8%) and rheumatoid arthritis (25.9%) were the most common comorbidities among infected individuals. Ivermectin uptake was high, with 94.3% of participants reporting that they had ever taken ivermectin at least once during previous community-directed treatment with ivermectin (CDTI) rounds. In comparison, a small proportion (5.7%) declined due to illness or blurred vision. Participants with tertiary education had approximately five times higher odds of taking ivermectin compared to those with no formal education (aOR = 4.62, 95% CI: 1.18–18.12, p = 0.028). Similarly, individuals who had lived in the community for more than 10 years had five times higher odds of adhering to ivermectin treatment than recent residents (aOR = 5.03, 95% CI: 1.11–22.8, p = 0.036), primarily due to a refusal of ivermectin, mainly because of side effects. Nearly half of the participants (48.9%) demonstrated poor knowledge of onchocerciasis.ConclusionOnchocerciasis remains present in Bafut, with ongoing transmission. Infection was associated with socio-demographic and behavioral factors. Non-communicable diseases were observed; however, no causal relationship can be inferred. Strengthening ivermectin uptake and health education may improve control.Clinical trial numberNot applicable.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12879-026-13505-1.Keywords: Onchocerciasis, Non-communicable diseases, Comorbidity, Continuous transmission, Ivermectin uptake, Cameroon Background Onchocerciasis, also known as river blindness, is caused by the filarial nematode worm Onchocerca volvulus and transmitted through the bite of infected blackflies of the genus Simulium spp, which breed in fast-flowing rivers [1]. The disease remains a major Neglected Tropical Disease (NTD) in most parts of sub-Saharan Africa [2]. In Cameroon, onchocerciasis is endemic in several regions, notably the Southwest, Northwest, North, Adamawa and Centre regions, despite over two decades of community-directed treatment with ivermectin (CDTI) [3–6]. Ignorance of the cause and mode of transmission of onchocerciasis, misconceptions about the disease, and poor treatment adherence have hampered the progress towards the elimination of the disease in endemic communities. In recent years, non-communicable diseases (NCDs) (hypertension, diabetes, rheumatoid arthritis, cancers, and cardiovascular diseases have been on the rise in most communities due to lifestyle changes. Globally, 41 million people die every year from NCDs; 17 million of these persons die before the age of 70years, and the majority (77%) reside in low and middle-income countries (LMICs). This epidemiological transition with rising NCDs and onchocerciasis creates a double burden for affected communities in Cameroon. The most common risk factors contributing to NCDs are unhealthy diets, physical inactivity, exposure to tobacco, smoke, alcohol abuse, overweight, raised blood pressure, raised cholesterol, and high blood sugar levels [7]. Detection and management of NCDs at an early stage can prevent complications and premature deaths. In onchocerciasis-endemic communities, the risk of developing NCDs increases with Onchocerca volvulus parasite load or with the adverse effects of ivermectin [8]. A preliminary study conducted in Bafut Health District, Cameroon, in 2022 reported a high prevalence of NCDs coexisting with onchocercal ocular and skin disease [9]. The co-existence of onchocerciasis with these chronic conditions may complicate the management of the disease. Community Health Workers (CHWs) have reported that during CDTI, people with arthritis have often refused to adhere to treatment because of adverse effects they experienced after taking ivermectin. There is little or no available data on the comorbidities of onchocerciasis and NCDs, especially in rural endemic communities like Bafut. The results may have been noted in health centers but not documented for the public. Apart from the refusal to take ivermectin due to adverse effects, other factors, such as current knowledge of onchocerciasis, also need to be assessed. Data obtained in this study will provide useful baseline information for appropriate interventions and improve public health policy on the management of patients living with both onchocerciasis and NCDs. The purpose of this study was to assess the prevalence of onchocerciasis, its comorbidity with selected NCDs, and determinants of continued onchocerciasis transmission in Bafut Health District. Methods Study design This was a community-based, cross-sectional study with health facility-based recruitment conducted from June to July 2024 at the Bafut Health District (BHD) to assess the impact of comorbidity of onchocerciasis and non-communicable diseases such as hypertension, diabetes, and rheumatoid arthritis. Following announcements through community leaders and churches, eligible community members aged 30 years and above (based on a preliminary survey indicating a higher burden of NCDs in this age range) presented themselves at designated health facilities for enrollment and data collection. Study site The BHD is one of the twenty-one health districts in the northwest region [10], with fourteen health areas, some of which are hypo-endemic (Mambu, Nsem, Nchum and Nsoh), meso-endemic (Mforya, Mankanikong, Manji, Belingyie and Atulah) or hyper-endemic (Mbakong, Mankwi and Buwe) for onchocerciasis by the Bafut District Health Service during the REA of oncho endemicity in 2004 [11]. The Bafut Health District, with an estimated population of over 70,000 inhabitants [12], is situated at Latitude 6°10′N and Longitude 10°06′E, in the Northwest Region of Cameroon. Administratively, Bafut Sub-Division is one of the five sub-divisions in the Mezam Division, and covers an area of roughly 340 km2. It is located in the western grass field geographic region, which includes Cameroon’s Northwest Region and surrounding grassland areas. Bafut sub-division is drained by the River Mezam (main collector) and its tributaries (Fig. 1). The main collector and its tributaries form a sparse and roughly rectangular drainage pattern. The presence of forested areas with fast-flowing rivers, high temperatures, rainfall, and human activities favours the development of Onchocerca vectors and is a key determinant of onchocerciasis occurrence. Bafut health areas and rivers [13]. (A) Cameroon map showing the position of the Bafut sub-division. (B) Map of the North West Region of Cameroon, locating the Bafut sub-division. (C) Map of Bafut sub-division showing study sites Study population Community members were mobilized through church announcements made by the respective Chiefs of Centres (COCs), and 282 male and female participants enrolled at designated health facilities. In order to ensure prolonged exposure to blackfly bites, improve accuracy when evaluating long-term ivermectin uptake, and exclude temporary residents who may not reflect true transmission dynamics, participants aged 30 years or older who had resided in Bafut for at least five years prior to the study, and who provided written informed consent, were included in the study. Individuals were excluded if they were non-residents, had not provided consent, or were critically ill at the time of recruitment. Sample size and sampling method The minimum sample size was calculated using Lorentz’s formula as follows: Where z2 = (1.96)2, p = previous onchocerciasis prevalence and q = 1-p, d2 = (0.05)2. The parameter p was derived from the prevalence of onchocerciasis among adults aged ≥ 30 years reported by Siewe-Fodjo et al. [14]. In that study, 37 of 221 individuals aged 30 years or older were skin-snip-positive (Table 2 in Siewe-Fodjo et al. [14]), corresponding to a prevalence of 16.7%, which is comparable to the age distribution of our target population. As this estimate was based on skin-snip–confirmed infection, consistent with our parasitological case definition, it was considered an appropriate baseline estimate. A 10% adjustment for potential non-response was applied, resulting in a final required sample size of 282 participants. Table 2Relationship between sociodemographic characteristics and composite onchocerciasis (palpable nodules and/or skin-snip positivity)VariableCrude OR (95% CI)p-value (Crude)Adjusted OR (95% CI)p-value (Adjusted) Gender Male1(ref)Female6.54 (2.28–18.79)< 0.001*6.58 (2.30–18.87)< 0.001* Age group (years) < 391(ref)40–492.47 (0.76–8.40)0.132.57 (0.78–8.53)0.1250–591.49 (0.44–5.09)0.501.51 (0.44–5.12)0.49≥ 604.28 (1.41–12.98)0.01*4.30 (1.42–13.02)0.01* Educational level None4.52 (1.22–16.74)0.02*4.58 (1.24–16.91)0.02*Primary1.70 (0.49–6.05)0.401.72 (0.49–6.12)0.39Secondary0.45 (0.07–2.90)0.430.46 (0.07–2.97)0.42Tertiary1(ref) Marital status Single1(ref)Married3.98 (0.91–17.28)0.064.01 (0.92–17.41)0.06 Occupation Business1(ref)Farming5.92 (0.73–47.75)0.105.84 (0.71–48.01)0.11Salaried worker3.33 (0.36–30.58)0.293.22 (0.34–30.12)0.31OR=odds ratio; CI=confidence interval; 1(ref)=reference group, *Significant p values Relationship between sociodemographic characteristics and composite onchocerciasis (palpable nodules and/or skin-snip positivity) OR=odds ratio; CI=confidence interval; 1(ref)=reference group, *Significant p values A multistage sampling approach was employed. In the first stage, health areas within the Bafut Health District were stratified by endemicity level, and 12 were randomly selected for further analysis. These comprised four hypo-endemic communities (Mambu, Nsem, Nchum, and Nsoh), three hyper-endemic areas (Mbakong, Mankwi, and Buwe), and five meso-endemic areas (Mforya, Mankanikong, Manji, Belingyie, and Atulah). In the second stage, participants were recruited consecutively at designated health facilities on scheduled data collection days following community sensitisation. Eligibility criteria included being aged 30 years or older, residing in Bafut for at least five years, and providing informed consent. Exclusion criteria included critical illness, refusal to participate, or being a non-resident. Data collection Physical and clinical examination A routine physical examination involving palpation of nodules in all participants was performed by trained clinicians in all the designated health facilities following REMO/APOC guidelines [15]. Skin snip collection (test for onchocerciasis) Skin snips were collected from all participants by the laboratory technicians. Before the procedure, all wells in a micro-titration tray were labelled, and normal saline was placed in each well. Two skin snips were taken from the shoulder and the waist (iliac crest) of each participant using a new, sterile razor blade, cut into small pieces, and placed in a well labeled according to the participant’s number. The tray was then covered and incubated for 24 h to allow the microfilariae to emerge from the tissue. Each well was then examined microscopically (10x) for emerging Onchocerca volvulus mf, and their number was counted. After this first examination, the snip was transferred into another micro-titration tray containing saline solution, and after 24 h of incubation, it was re-examined as before. The use of two incubation steps for skin snips is a standard procedure employed by the National Programme for Onchocerciasis Control (PNLO/APOC), and this approach enables the detection of Onchocerca volvulus microfilariae (mf), which may emerge slowly from the tissue. Participants were considered positive when Onchocerca volvulus microfilariae (mf) were present in their skin sample. The positive samples were then preserved in a cryogenic vial containing 70% alcohol. Case definitions Primary outcome The primary outcome variable was the composite presence of onchocerciasis, defined as palpable nodules and/or skin-snipping positivity. Secondary measures Palpable nodules on clinical examination. Composite clinical prevalence is defined as the presence of positive skin snips or palpable nodules. Blood pressure measurement Blood pressure was measured before skin-snip collection to avoid procedure-related elevation. A blood pressure (BP) machine (Lovia, Shenzhen Noto-Tech Electronics Co., Ltd, China) was used to measure the systolic and diastolic pressure of each participant as follows: The participant was asked to sit on a chair, and the blood pressure cuff was snug around the upper arm, one inch (~ 2.5 cm) above the antecubital fossa. The hand was placed on the table at rest, and the “start” button was pressed to begin the measurement. If the results were abnormal, the participants were advised to increase their water intake, consume more vegetables and fruits, reduce their salt intake, limit alcohol consumption, and exercise regularly. A regular blood pressure reading is 120/80mmHg or lower. High blood pressure was defined as 140/90mmHg or higher. Detection of diabetes and rheumatoid arthritis using point-of-care diagnostic tests Venous blood samples (2 ml) were collected from participants under aseptic conditions through standard venipuncture into dry tubes, labelled with unique identifiers. Blood glucose levels were measured immediately using the SD Codefree Blood Glucose Monitoring System (SD Biosensor, India) with manufacturer-supplied test strips, in accordance with the standard operating procedures. Results were classified as fasting or random blood sugar depending on the participant’s meal status. Reference values were defined as 74–106 mg/dL for fasting glucose and < 140 mg/dL for random glucose [16]. For rheumatoid arthritis, blood samples were centrifuged, and serum analyzed using the Rheumatoid Factor (RF) Latex Agglutination Test (Fortress Diagnostics, UK). Each assay run included both positive and negative controls to verify the performance of the reagent. A 50 µl serum sample was mixed with the latex reagent on a test card and gently rotated for two minutes. The presence of visible agglutination indicated an RF concentration ≥ 8 IU/ml, consistent with a positive rheumatoid arthritis result. Survey instrument A pre-tested, structured, interviewer-administered questionnaire (Supplementary File 1) was used to collect data on participants’ sociodemographic characteristics, history of non-communicable disease (NCD) diagnosis, knowledge of onchocerciasis, and factors associated with onchocerciasis transmission. The instrument comprised 25 items. Ten items captured sociodemographic information, including health area, endemicity level, age, sex, occupation, religion, marital status, education, and duration of residence in Bafut. Six items assessed participants’ knowledge of onchocerciasis, focusing on its cause, transmission, prevention, and treatment. Four items assessed knowledge and self-reported status of NCDs, and three items captured signs and symptoms of onchocerciasis. Two items assessed ivermectin uptake and associated side effects, specifically asking participants whether they had ever taken ivermectin during any previous CDTI round and, if not, their reasons for not doing so. This variable reflects lifetime or historical exposure to ivermectin and does not represent annual therapeutic coverage. Statistical analysis All data were double-entered into Excel and analysed using SPSS Statistics 26 (SPSS Inc., Chicago, USA). Descriptive statistics were used to summarise sociodemographic characteristics, onchocerciasis knowledge, prevalence of non-communicable diseases (NCDs), ivermectin uptake, and clinical manifestations. The primary dependent variable in the regression analysis was the composite presence of onchocerciasis, defined as palpable nodules and/or skin-snipping positivity. Associations between categorical variables and infection status were assessed using the Pearson Chi-square (χ²) test. To identify factors associated with continued onchocerciasis transmission, multivariate logistic regression was performed, including only variables with p < 0.20 in the bivariate analysis to control for potential confounding. Results were presented as adjusted odds ratios (aORs) with corresponding 95% confidence intervals (CIs). Statistical significance was set at p < 0.05. Results A total of 282 respondents participated in the study. The majority of participants were females (73.4%), above 60 years old (37.6%), had attended primary education (56%), and were farmers 219(77.7%) who had lived in the study area for a duration of 20-40yrs (45.7%) (Table 1). Table 1Socio-demographic characteristics of the study population (n´=282)CategoryFrequency (n)Percentage (%) Gender Male7526.6Female20773.4 Age group < 394214.940–496121.650–597325.9> 6010637.6 Level of education None6523Primary15856Secondary3412.1Tertiary258.9 Occupation None93.2Farming21977.7Salaried worker3311.7Business217.4 Marital status Single3612.8Married24687.2 Religion Christianity282100 Duration lived in the area < 203612.820–4012945.7> 4011741.5 Socio-demographic characteristics of the study population (n´=282) Prevalence of onchocerciasis The prevalence of onchocerciasis was determined based on the presence of observable palpable nodules/or a positive skin snip. Among the 282 participants, 43(15.2%) had palpable nodules, 17(6.0%) were positive for skin snip, and 6(2.1%) presented with both palpable nodules and a positive skin snip (Fig. 2). Thus, the composite clinical prevalence of onchocerciasis in this study was 54 (19.1%), determined by combining cases identified through palpable nodules and skin snip positivity. Distribution of onchocerciasis diagnostic findings among study participants (N = 282) After adjusting for potential confounders, sex, age, and education remained significantly associated with individual onchocerciasis infection status (p < 0.05). Female participants had 6.6-times higher odds of infection than males (aOR = 6.58, 95% CI 2.30–18.87, p < 0.001). Participants aged ≥ 60 years had 4.3-times higher odds of infection compared to those < 39 years (aOR = 4.30, 95% CI 1.42–13.02, p = 0.01). Likewise, those without formal education had 4.6 times higher odds of being infected compared with participants who had a tertiary education (aOR = 4.58, 95% CI: 1.24–16.91, p = 0.02) (Table 2). Prevalence of non-communicable diseases and onchocerciasis comorbidities The prevalences of rheumatoid arthritis, hypertension, and diabetes among the participants were 19.1%, 18.8%, and 2.1%, respectively. Among participants with onchocerciasis, the prevalences of rheumatoid arthritis, hypertension, and diabetes were 25.9%, 27.8%, and 3.7%, respectively. The prevalence of combined hypertension and rheumatoid arthritis was 2.8% in the study population and 11.1% among participants with onchocerciasis. Although higher proportions of these conditions were observed among participants with onchocerciasis compared to those without infection, no statistically significant associations were found for individual conditions (p > 0.05). However, the co-occurrence of hypertension and rheumatoid arthritis was significantly associated with onchocerciasis (p < 0.001) (Table 3). Table 3Prevalence of non-communicable diseases and onchocerciasis comorbiditiesDiseaseStudy populationn(%) (n = 282)Oncho prevalenceP-valueOncho Positive n(%) (n = 54)Oncho Negative n(%) (n = 228)Rheumatoid Arthritis54(19.1)14(25.9)40(17.5)0.52Hypertension53(18.8)15(27.8)38(16.7)0.17Diabetes6(2.1)2(3.7)4(1.8)0.47Hypertension + Arthritis8(2.8)6(11.1)2(0.9)< 0.001**Significant p values Prevalence of non-communicable diseases and onchocerciasis comorbidities *Significant p values Clinical manifestations associated with onchocerciasis versus onchocerciasis comorbidities Clinical manifestations observed among participants included skin or eye itching, skin changes, edema, and visual impairment. Among participants with onchocerciasis, skin or eye itching (85.2%) and blindness or blurred vision (59.3%) were the most frequently reported manifestations. Skin changes (9.3%) and edema (3.7%) were less common. In comparison, lower proportions of these manifestations were observed among participants without onchocerciasis. Although differences in proportions were noted, no statistically significant associations were found between clinical manifestations and onchocerciasis status (p > 0.05) (Table 4). Table 4Clinical manifestations associated with onchocerciasis versus onchocerciasis comorbiditiesManifestationOncho positive n (%) (n = 54)Oncho negative n (%) (n = 228)p-valueItching skin/eyes46 (85.2)52(22.8)0.70Skin change5 (9.3)2(0.9)0.06Edema2 (3.7)0(0.0)0.68Blindness / blurred vision32 (59.3)9(3.9)0.24 Clinical manifestations associated with onchocerciasis versus onchocerciasis comorbidities Factors associated with continued transmission of onchocerciasis Knowledge of onchocerciasis More than half of the study population (51.1%) were aware of onchocerciasis. Although only 53.2% of them chose “parasite” as the cause and identified the blackfly as a vector for the transmission of onchocerciasis, 95.5% agreed that onchocerciasis was preventable and could be treated with ivermectin. However, very few (3.2%) said it could also be treated by herbs (Table 5). Table 5Knowledge of onchocerciasisCharacteristicsNo. of participants (%) Cause mosquito bites90(31.9) Parasite 150(53.2) I don’t know42(14.9)* 1Right Knowledge 150(53.2) Mode of transmission sharing clothes12(4.3)mosquito bites90(31.9) Blackfly 150(53.2) I don’t know30(10.6) * 2 Right Knowledge 150(53.2) Do you think onchocerciasis is preventable? No13(4.6) Yes 269(95.4) * 3 Right Knowledge 269(95.4) How is onchocerciasis treated? Mectizan 269(95.4) Herbs 9(3.2) I don’t know9(3.2) * 4 Right Knowledge 269(95.4) Knowledge score Good knowledge144(51.1)Poor knowledge138(48.9)*Right knowledge: * 1 if response is parasite, * 2 if response is blackfly, * 3 if response is yes, * 4 if response is either Mectizan or Herbs. Good knowledge: right knowledge of at least 3 knowledge characteristics; otherwise, poor knowledge Knowledge of onchocerciasis *Right knowledge: * 1 if response is parasite, * 2 if response is blackfly, * 3 if response is yes, * 4 if response is either Mectizan or Herbs. Good knowledge: right knowledge of at least 3 knowledge characteristics; otherwise, poor knowledge Ivermectin uptake among the study participants Ivermectin has been distributed in the Bafut Health District for nearly two decades. In this study, uptake refers to self‑reported history of ever taking ivermectin during past CDTI rounds, not annual coverage for a particular distribution year. Overall, historical uptake was high: 266 (94.3%) participants reported taking ivermectin at least once in previous campaigns, while 16 (5.7%) reported never taking it, citing reasons such as sickness and blurred vision. Among participants who refused ivermectin, 13 (81.3%) were females, and 6 (37.5%) were in the 40–49 years age group, representing the majority of those who declined treatment (Table 6). Table 6Ivermectin uptake among study participants (n = 282)VariableIvermectin uptakep-valueYes n (%)No n (%) Gender Male145 (96.0)6 (4.0)0.43Female120 (93.7)8 (6.3) Age group (years) < 3983 (97.6)2 (2.4)0.5740–4946 (90.2)5 (9.8)50–5940 (94.5)3 (5.5)≥ 6028 (92.9)2 (7.1) Educational level None59 (90.8)6 (9.2)0.03*Primary39 (94.9)2 (5.1)Secondary34 (97.1)1 (2.9)Tertiary25 (100.0)0 (0.0) Occupation Business/Salaried71 (95.8)3 (4.2)0.48Farming92 (93.6)6 (6.4)None20 (88.9)2 (11.1) Marital status Single84 (96.4)3 (3.6)0.44Married181 (93.5)9 (6.5) Duration of residence (years) < 533 (86.8)5 (13.2)0.04*5–1061 (93.8)4 (6.2)> 10171 (96.6)6 (3.4)*Significant p values Ivermectin uptake among study participants (n = 282) *Significant p values Uptake of ivermectin remained high across most socio-demographic characteristics, with no significant differences observed by sex, age, occupation, or marital status (p > 0.05). In the crude analysis, educational level and duration of residence were associated with ivermectin uptake. In the multivariate logistic regression model, participants with tertiary education had significantly higher odds of ivermectin uptake compared with those with no formal education (aOR = 4.62, 95% CI: 1.18–18.12, p = 0.028). Similarly, participants who had resided in the community for more than ten years had higher odds of ivermectin uptake than those who had lived in the area for less than five years (aOR = 5.03, 95% CI: 1.11–22.8, p = 0.036) (Table 7). Table 7Factors associated with ivermectin uptakeVariableCrude OR(95% CI)p-value (Crude)Adjusted OR(95% CI)p-value (Adjusted) Educational level None1(ref)Primary1.89 (0.33–10.9)0.04*2.01 (0.29–13.8)0.03*Secondary3.42 (0.36–32.1)0.274.22 (0.39–45.8)0.22Tertiary4.95 (1.12–20.8)0.035*4.62 (1.18–18.12)0.028* Duration of residence (years) < 51(ref)5–102.33 (0.64–8.48)0.02*2.49 (0.61–10.2)0.04*> 104.32 (1.16–16.07)0.029*5.03 (1.11–22.8)0.036*OR=odds ratio; CI=confidence interval; 1(ref)=reference group; *Significant p values Factors associated with ivermectin uptake OR=odds ratio; CI=confidence interval; 1(ref)=reference group; *Significant p values Discussion This study examined the current prevalence of comorbidity between onchocerciasis and hypertension, rheumatoid arthritis, and diabetes, as well as the determinants of continued onchocerciasis transmission in the Bafut Health District after more than two decades of annual ivermectin distribution. The study involved 282 participants, predominantly females (73.4%), aged 59 years and above (37.6%). Most participants had a primary level of education (56.0%), and the main occupation of the participants was farming (77.7%). This can be explained by the fact that the majority of church attendees are women, who may have heard the church announcements and presented themselves at designated health facilities more often than men. Also, men in the crisis zones scarcely go out because they are victims of attacks than women [15]. While over 2 decades of MDA in Cameroon have reduced transmission in some regions, such as the Adamawa [17], onchocerciasis persists in the Bafut Health District, as confirmed by our findings. The skin-snip prevalence in our study (6.0%) is lower than that reported in Tombel (21.6%) and similar to that in rural endemic settings where diagnosis relied solely on skin snips [17, 18]. In contrast to some earlier studies reporting higher infection levels in hyperendemic settings, our findings are comparable to those from rural mesoendemic communities with long-standing ivermectin distribution, such as the Tombel and Yabassi Health Districts, where skin-snip–based prevalence ranged from 21% to 26% [17, 18]. These similarities reflect comparable ecological and epidemiological contexts, as well as the use of similar parasitological diagnostic methods. Differences observed between study sites may be attributed to variations in local transmission dynamics, variations in vector density, adherence to ivermectin over time, and baseline endemicity prior to mass drug administration. Serologic OV16 IgG4 testing detects exposure to onchocerciasis and is primarily used where transmission is suspected to be interrupted. It does not replace parasitological diagnosis when estimating active infection in high-prevalence settings. Our prevalence estimate may be biased due to methodological and sampling limitations. When individual onchocerciasis infection status was analyzed in relation to demographic characteristics, we found significant associations with sex, age, education, marital status, and health area (p < 0.05). A higher prevalence was observed in females (27.1%) compared to males (5.3%). This may be explained by the fact that most married women in Bafut who have not received any education are primarily farmers who work to support their families, especially in hyperendemic areas. It has been suggested that females work longer on the farm and with exposed bodies than males, thereby making them more prone to bites from blackflies [6, 18]. Our study found a higher composite prevalence of onchocerciasis among farmers (23.7%). This differs from the study conducted in Yabassi Health District by Kamga et al. [6], who recorded a higher composite prevalence in males than in females. The differences in infection rates with regard to sex could be due to occupational exposure and individual susceptibility [19]. The high prevalence observed in our study among participants aged 40 and above may be due to individuals in this age group being most active in outdoor activities (such as farming, sand mining, tapping, and fishing), as confirmed by other studies [20]. This is also consistent with another study reporting a higher prevalence in the older age group [19, 21]. Non-communicable diseases have been on the rise in most societies because of lifestyle and behavioural changes. The prevalences of rheumatoid arthritis, hypertension, and diabetes in the study population were 19.1%, 18.8%, and 2.1%, respectively. Among participants with onchocerciasis, the prevalences were 25.9%, 27.8%, and 3.7%, respectively. Although higher proportions of these conditions were observed among participants with onchocerciasis compared to those without infection, these differences were not statistically significant (p > 0.05). Hypertension was the most frequent non-communicable condition among participants with onchocerciasis (27.8%). Although this finding is based on a small number of cases, it is consistent with previous studies that have explored possible links between chronic infections, inflammation, and cardiovascular conditions [22, 23]. Only 2 (3.7%) participants with onchocerciasis were diagnosed with diabetes. This observation is in line with findings by Rajamanickam and Babu [24], who reported a lower occurrence of diabetes among individuals with helminth infections, possibly related to immunomodulatory effects described in the literature [25]. A significant association was observed between onchocerciasis and the combined occurrence of hypertension and rheumatoid arthritis (p < 0.001). While underlying immunological mechanisms have been proposed, including alterations in cytokine profiles and immune responses [22]. Additionally, immune complexes formed when microfilariae die can cause deposition in joints, leading to swelling and pain, which are characteristic of arthritis. Interestingly, inflammatory cytokines Th17 and Th2 have been implicated in rheumatoid arthritis and a hyperreactive form of onchocerciasis [26]. Amongst factors assessed for continued transmission were knowledge of the disease, presence of NCDs, demographic characteristics, and uptake of ivermectin. Our analysis of knowledge of onchocerciasis among the participants showed that 51.1% of them had a good knowledge of onchocerciasis, and 53.2% correctly identified the blackfly as a vector of transmission, including the signs and symptoms associated with it, because of the endemicity of the infection in the study area and continuous sensitisation by health care providers in the area. This result is consistent with the findings of other studies [27, 28]. However, these results contradict the findings of a study by Wogu and Okaka [22], which reported that 57% of participants lacked knowledge of transmission. Awareness of available treatments is crucial, as a lack of knowledge could lead to non-compliance and ongoing transmission. More than 90% of participants agreed that ivermectin was an effective way to prevent and treat onchocerciasis, apart from using herbs. This is because they had been witnessing the annual distribution of the drug and willingly took it for treatment, as confirmed in our results. A similar study, conducted by Adeoye and colleagues in Southwestern Nigeria, reported that 92% of participants viewed ivermectin as the preferred drug for the prevention and treatment of onchocerciasis [29]. Additionally, a study conducted in Southwest Ethiopia found that 93.3% of respondents perceived onchocerciasis as preventable [30]. It was commendable to observe in our study that > 90% of participants knew the importance of taking ivermectin for a significant reduction in morbidity, an observation that is consistent with studies conducted in other hyper-endemic communities of Edo and Imo States, Nigeria, and Ethiopia [29]. Although a composite clinical prevalence of 19.1% was observed, WHO elimination thresholds are based on parasitological indicators. The skin-snip prevalence in this study was 6.0%, indicating that transmission persists, but interruption remains achievable with strengthened control efforts. Our study found a high self-reported history of ivermectin uptake, with 94.3% of participants indicating that they had taken the drug at least once in previous CDTI years. This finding is similar to levels reported in endemic regions of Ethiopia and Nigeria, where therapeutic coverage often exceeds 90% [31, 32]. Among the 266 participants who reported ever using ivermectin, 54(20.3%) were classified as positive for onchocerciasis based on the composite definition of palpable nodules and/or skin-snip positivity. This finding should be interpreted with caution, as ivermectin primarily reduces microfilarial load and therefore affects skin-snip positivity but does not eliminate adult worms, which may persist as nodules. In addition, factors such as irregular treatment, timing of the last dose, and continued exposure to infective blackfly bites may contribute to ongoing infection. Despite high historical uptake, persistent infection was observed, indicating that having ever taken ivermectin does not necessarily equate to consistent adherence over years, nor does it reflect current-year programmatic effectiveness. Studies in endemic settings have consistently attributed poor compliance as a critical factor sustaining transmission [33]. In our study, refusal to take ivermectin was strongly associated with infection status, and 5.7% of participants commonly cited fears of drug-related adverse effects, such as blurred vision, palpitation associated with hypertension, and sickness. This is supported by similar results obtained in an endemic area of Guatemala and in Okpuje, an endemic community in Edo State, Nigeria [29]. Apart from the above factors, an interruption in ivermectin distribution due to the ongoing sociopolitical unrest in the study area could also contribute to the continued transmission of onchocerciasis, as confirmed by previous studies [14, 34]. Our findings demonstrate that high reported ivermectin uptake alone does not equate to effective control or interruption of transmission. Persistent infection despite good coverage underscores the need to go beyond numerical targets and focus on behavioral adherence, pharmacovigilance, and trust in community-directed treatment systems. Efforts must focus on strengthening health education, continuous supervision, and the management of adverse events to address fear-driven noncompliance. Furthermore, integration of non-communicable disease screening and management into onchocerciasis programs could enhance treatment acceptance, especially among individuals who associate drug side effects with pre-existing health conditions. Sustained elimination in conflict-affected and hard-to-reach areas such as Bafut will require innovative community engagement, flexible delivery mechanisms, and uninterrupted drug distribution cycles. Only through such comprehensive and context-sensitive approaches can the gains of long-term mass ivermectin administration be consolidated and the goal of onchocerciasis elimination brought within reach. Limitations The study was limited to adults aged 30 years and above; therefore, the results cannot be generalized to younger adults. Some older participants had difficulty understanding certain questions due to language barriers, which may have affected their responses. Moreover, the use of convenient random sampling may have excluded individuals with severe morbidity. Additionally, information on ivermectin uptake relied on self-reporting, which introduces recall and reporting bias. Laboratory confirmation was limited by the unavailability of the OV16 IgG ELISA, which restricted the detection of both active and past infections. Likewise, our study was limited to 12 health areas within the district due to socio-political unrest. Selection bias may have occurred because symptomatic individuals who did not attend health facilities were excluded, thereby contributing to the predominance of female participants and potentially influencing the prevalence estimates. Single-visit BP screening and the absence of anthropometric data due to field constraints were additional limitations to affirming NCD diagnosis in participants. The predominance of female participants likely reflects selection bias arising from facility-based enrollment and incomplete community-wide mobilization. Finally, the cross-sectional design of this study limits the ability to establish temporal or causal relationships between onchocerciasis and the observed non-communicable conditions. The findings should therefore be interpreted as co-occurrences within the study population rather than evidence of causation. Conclusions Onchocerciasis remains present in the Bafut Health District, with evidence of ongoing transmission despite long-term ivermectin distribution. The burden of infection, as assessed by both parasitological and clinical indicators, underscores the need for sustained control efforts. Clinical manifestations such as itching and visual impairment were commonly reported among affected individuals. Infection was associated with socio-demographic, behavioural, and environmental factors, including age, sex, education, knowledge of the disease, ivermectin uptake, and proximity to rivers and forested areas. Although selected non-communicable conditions were observed among participants, no causal relationship with onchocerciasis can be inferred. Strengthening community knowledge and improving adherence to community-directed treatment with ivermectin remain essential to support progress toward elimination. Electronic Supplementary Material Below is the link to the electronic supplementary material. Supplementary Material 1 Acknowledgements We would like to thank the study participants who made this study realistic, and the Chief of Centers for the permission granted to conduct the study in the health facility. Abbreviations African Programme for Onchocerciasis Control Bafut Health District Blood Pressure Community-Directed Treatment with Ivermectin Community Health Workers Chief(s) of Centre District Medical Officer Enzyme-Linked Immunosorbent Assay Immunoglobulin G Ivermectin Low- and Middle-Income Countries Mass Drug Administration Microfilariae Non-Communicable Disease(s) Neglected Tropical Disease(s) Onchocerca volvulus 16 kDa antigen Programme National de Lutte contre l’Onchocercose Rheumatoid Arthritis Rapid Epidemiological Assessment Rheumatoid Factor World Health Organization Author contributions IUA, PAA, MUA conceived and designed the experiments. IUA and PAA conducted the study. IUA and MUA performed the analysis. IUA, PAA, MUA, TNA drafted the manuscript. All authors contributed to the revision of the manuscript prior to submission. Funding This study received no external funding. Data availability The dataset used in the present study is available from the corresponding author upon reasonable request. Declarations Ethics approval and consent to participate Ethical clearance for the study was obtained from the Institutional Review Board of the University of Bamenda (No.2024/0628H/UBa/IRB). Administrative authorisations were also granted by the Regional Delegation of Public Health and the District Medical Officer (DMO) of Bafut Health District. Before data collection, these approvals were presented to the Chiefs of Centres (COCs) of the selected health facilities. Before recruitment, study procedures were explained to participants in both English and the Bafut dialect by laboratory technicians or other trained staff fluent in the local language. Written informed consent was obtained from all respondents, either by signature or thumbprint, after a detailed explanation of the study’s nature and objectives. Participation was entirely voluntary. Data collected was treated with strict confidentiality and stored on password-protected computers. All participants were handled per the principles of the Declaration of Helsinki on the ethical use of humans in biomedical research. Consent for publication Not Applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1 Data Availability Statement The dataset used in the present study is available from the corresponding author upon reasonable request.